2023 annual financial data
SpyGlass Pharma 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -14,230,365 USD and net income was -13,318,990 USD.
Operating cash flow was -12,277,733 USD.
Get free SpyGlass Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -14,230,365 USD
- Net income
- -13,318,990 USD
- Operating cash flow
- -12,277,733 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all SpyGlass Pharma financial years